Evidence map›Paper›PMID 35208876›Full record

ArticleMicroorganisms2022

Whole-Genome Sequencing Enables Molecular Characterization of Non-Clonal Group 258 High-Risk Clones (ST13, ST17, ST147 and ST307) among Carbapenem-Resistant

Gabriel Mendes, João F Ramalho, Ana Bruschy-Fonseca, Luís Lito, Aida Duarte, José Melo-Cristino, Cátia Caneiras

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Characterization of aMicrobiology spectrum · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Microbiology spectrum · 2024
    Article
  17. Carbapenem-resistantJAC-antimicrobial resistance · 2024
    Article
  18. Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gabriel MendesLaboratório de Investigação em Microbiologia na Saúde Ambiental (EnviHealthMicro Lab), Instituto de Saúde Ambiental (ISAMB), Faculdade de Medicina, Universidade de Lisboa (ULisboa), 1649-026 Lisboa, Portugal.ORCID 0000-0003-2610-8522
João F RamalhoLaboratório de Investigação em Microbiologia na Saúde Ambiental (EnviHealthMicro Lab), Instituto de Saúde Ambiental (ISAMB), Faculdade de Medicina, Universidade de Lisboa (ULisboa), 1649-026 Lisboa, Portugal.ORCID 0000-0002-2312-225X
Ana Bruschy-FonsecaLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Norte, 1649-035 Lisboa, Portugal.
Luís LitoLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Norte, 1649-035 Lisboa, Portugal.
Aida DuarteFaculdade de Farmácia, Universidade de Lisboa, 1649-033 Lisboa, Portugal.ORCID 0000-0002-0616-4650
José Melo-CristinoLaboratório de Microbiologia, Serviço de Patologia Clínica, Centro Hospitalar Universitário Lisboa Norte, 1649-035 Lisboa, Portugal.
Cátia CaneirasLaboratório de Investigação em Microbiologia na Saúde Ambiental (EnviHealthMicro Lab), Instituto de Saúde Ambiental (ISAMB), Faculdade de Medicina, Universidade de Lisboa (ULisboa), 1649-026 Lisboa, Portugal.ORCID 0000-0002-3735-8554
University of Lisbon · PTCentro Hospitalar Lisboa Norte · PT

Funding

Fundação para a Ciência e Tecnologia 2020.07736.BDFundação para a Ciência e Tecnologia UIDB/04295/2020Fundação para a Ciência e Tecnologia UIDP/04295/2020
6 · The paper itself

Abstract

The carbapenem-resistant Enterobacterales (CRE) strains have been identified by the World Health Organization as critical priority pathogens in research and development of diagnostics, treatments, and vaccines. However, recent molecular information about carbapenem-resistant

Indexed as

carbapenem-resistancehypermucoviscosity (HMV)hypervirulentKlebsiella pneumoniaeKPC-3molecular epidemiologyNDM-1OXA-181PortugalST13ST147ST17ST307ST39-KL62whole-genome sequencing (WGS)

Identifiers

PMID35208876
PMCPMC8875758
OpenAlexW4213108610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.